KLAS Research, the independent healthcare analyst firm, interviewed Assort Health customers about their results using AI agents across scheduling, after-hours coverage, triage, outbound workflows, and more.
%201.avif)
KLAS* found that respondents viewed Assort’s AI-driven scheduling automation as highly effective in reducing wait times, lowering workloads, and improving patient experiences. 83.3% report seeing outcomes immediately.

Customers reported achieving outcomes including 24/7 self-scheduling, reduced call-center workload and wait times, improved information accuracy, and reduced staff requirements.
KLAS Research is a healthcare IT research and insights firm that collects feedback from healthcare providers and payers about the technologies and services they use. Its research is designed to reflect customer experience and help healthcare organizations evaluate technology vendors.
The Assort Health KLAS Emerging Company Spotlight is an August 2026 report examining how healthcare organizations are using Assort’s AI-driven patient access automation. The report covers customer experience, product capabilities, partnership, outcomes, and areas for improvement.
KLAS found that customers gave Assort Health A+ ratings for likelihood to recommend, partnership, fair and transparent charging, and willingness to buy again. Assort also received a 94.5 overall performance score, based on limited data. Customers reported outcomes including reduced call-center workload and wait times, improved information accuracy, 24/7 self-scheduling, and reduced staff requirements.
Healthcare organizations interviewed by KLAS reported using Assort for after-hours coverage, inbound scheduling, intelligent triage and routing, FAQs, outbound scheduling, and task and case management. Assort’s AI agents are designed to support patient access workflows across phone, scheduling, routing, follow-up, and connected systems.
KLAS interviewed 8 individuals from 6 healthcare organizations for the Assort Health Emerging Company Spotlight. Because the sample size is limited, KLAS identifies the findings as early data and marks applicable performance measures accordingly.
The full Assort Health 2026 Emerging Company Spotlight is available on the KLAS Research website. Assort Health cannot host or distribute the full report directly, so visitors should access it through the official KLAS report page.